Eterna is building a biomaterials regeneration platform, with an initial focus on enamel and bone repair.
Eterna Regeneratives has raised €3.5M across 1 funding round from 2 investors, most recently a Seed round in Sep 2026. Based in London, UK; active in Healthtech. Data as of 17 Sept 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-17 | Seed | €3.5M |
| Hoxton Ventures,The Venture Collective |
| View deal → |
